NewsRx

Search our medical news database

HIV/AIDS

Studies from G. Singh and co-authors have provided new information about HIV/AIDS

Published in AIDS Weekly, December 8th, 2008

"The necessity of understanding the detailed mechanism of flap dynamics in designing HIV-1 protease inhibitors is immense. Crystal structures have provided us with a static overview of various conformations of the enzyme, but the existence of strong interplay among various conformations came to the fore only after dynamics studies," scientists in Madras, India report.

"Here we elucidate the mechanistic aspects of HIV-1 protease flap closing upon binding inhibitors using all-atom molecular dynamics simulations. The unrestrained simulations reproduced not only the correct inhibitor-bound protease closed structures but also the structural water molecule which is seen in...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook